University of Colorado, Denver: HIV Infections trials

The registry lists 19 HIV Infections studies with University of Colorado, Denver as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 1 2Phase 2 2Phase 3 1Phase 4 2No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• V+PSF-M for Tobacco Cessation in HIV Care in IndiaRecruitingNCT05786547Phase 3
• Happy Homes, Healthy Families: A Relationship Strengthening Intervention for Pregnant Couples Affected by HIV in ZambiaCompletedNCT04729413Not applicableResults posted
• Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)CompletedNCT03126370Phase 4Results posted
• Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young AdultsCompletedNCT02474901Phase 2Results posted
• Quantifying Drug Adherence and Drug Exposure to Antiretroviral TherapyCompletedNCT02012621Results posted
• Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young AdultsCompletedNCT01685372Phase 2Results posted
• Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 InfectionCompletedNCT00414518Not applicableResults posted
• Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIVTerminatedNCT04249037Phase 4
• Mitochondria in HIV and Aging (MITO+)CompletedNCT03489421
• Impact of ART Adherence on HIV Persistence and InflammationCompletedNCT02797093
• Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of TenofovirCompletedNCT02588287Not applicable
• Antiviral Pharmacology and Adherence in Drug UsersCompletedNCT02573376Not applicable
• Mother and Infant Visit Adherence and Treatment Engagement StudyCompletedNCT02491177Not applicable
• Compassionate Use of Ibalizumab for the Treatment of HIV InfectionNo longer availableNCT02028819
• Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine UsersCompletedNCT01161485Not applicable
• Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in UkraineCompletedNCT01159704Not applicable
• Effect of Antacids on the Pharmacokinetics of RaltegravirCompletedNCT00944307Phase 1
• Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk PreventionCompletedNCT00601237Not applicable
• A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV MedicationCompletedNCT00482963Phase 1